Overview

Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias

Status:
Terminated
Trial end date:
2019-06-18
Target enrollment:
Participant gender:
Summary
This research is being done so that we can look at the safety and efficacy of deferiprone in people with sickle cell disease or other anemias. Deferiprone is a drug that removes iron from the body. We will be comparing deferiprone with deferoxamine, another drug that removes iron from the body.
Phase:
Phase 4
Details
Lead Sponsor:
ApoPharma
Treatments:
Deferiprone
Deferoxamine